A major advance in cancer research is arising with the use of VHH fragments to reactivate dysfunctional p53. This crucial cancer protector protein is frequently inactivated in various types of tumors, causing https://toplistar.com/story24133431/nanobodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-tumor-therapy